NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
Details
- Buyer
- NHS England
- Supplier(s)
63 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- AGB Pharma
- Aguettant Ltd
- Alissa Healthcare Research Limited
- Amarox Ltd
- Aspire Pharma Ltd
- B. BRAUN MEDICAL LIMITED
- Bowmed Ibisqus Ltd
- Colonis Pharma Limited
- Consilient Health Ltd
- CST Pharma Limited
- Day Lewis Medical Ltd
- Desitin Pharma Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Ennogen HealthCare
- Esteve Pharmaceuticals Ltd
- Flexipharm Austrading Ltd
- FLYNN PHARMA LTD
- FRESENIUS KABI LIMITED
- GENNISIUM PHARMA
- Gerot Lannach UK Ltd
- GH Pharma Ltd
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Hameln Pharma Ltd
- Healthcare Pharma Ltd
- Ipca Laboratories UK Ltd
- Janssen Cilag Ltd
- Kent Pharma Ltd
- Lucane Pharma
- Macleods Pharma UK Limited
- Martindale Pharma
- medac Pharma LLP
- Medreich Plc
- Mercury Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- Morningside Pharmaceuticals Ltd
- Mylan
- Neuraxpharm UK Ltd
- Novumgen Limited
- Organon Pharmaceuticals UK Ltd
- Otsuka Pharmaceuticals UK Limited
- Panpharma UK Ltd
- PARI
- Perennial Pharma Ltd
- Pfizer Liimted
- Piramal Critical Care Ltd
- Ranbaxy (UK) Ltd
- Roma Pharmaceuticals Limited
- Rosemont Pharmaceuticals Ltd
- ROVI BIOTECH LIMITED
- Sandoz
- Seacross Pharmaceuticals Ltd
- Selective Supplies Ltd
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Teva UK Ltd
- Thornton and Ross
- Tillotts Pharma UK Ltd
- Torbay Pharmaceuticals
- Venture Healthcare Ltd
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Value
- £1
- Duration
- 3 years
- Topic
- Pharmaceutical products
- Published
- 14 May 2024
- Source
- uk:contracts_finder
Tender description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Timeline
- Completed: Award published14 May 2024Current notice
- Completed: Award date1 June 2024
- Next: Contract expiry date31 May 2027in 7 months
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 509£240.8m
- 445£6.2bn
- 408£112.0m
- 394£649.4m
- 324£1.2bn
- 321£24.6bn
- 291£1.6bn
- 259£3.1bn
- 163£126.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.